Response to androgen signaling (AS)-directed therapy after treatment with abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Post hoc analysis of study COU-AA-302 Meeting Abstract
| Authors: | Smith, M. R.; Matheny, S.; Saad, F.; Rathkopf, D. E.; Mulders, P. F. A.; de Bono, J. S.; Small, E. J.; Shore, N. D.; Fizazi, K.; Kheoh, T. S.; Li, J. H.; Todd, M. B.; Griffin, T. W.; Yu, M. K.; Ryan, C. J. |
| Abstract Title: | Response to androgen signaling (AS)-directed therapy after treatment with abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Post hoc analysis of study COU-AA-302 |
| Meeting Title: | 2014 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2014 Jan 30-Feb 1 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-02-01 |
| Language: | English |
| ACCESSION: | WOS:000335318100024 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.4_suppl.21 |
| Notes: | Meeting Abstract: 21 -- Genitourinary Cancers Symposium -- JAN 30-FEB 01, 2014 -- San Francisco, CA -- S -- Source: Wos |
